The groundbreaking therapy of this peptide represents a exciting development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide964142.bcbloggers.com/40761289/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment